Article
Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice.
Endocrinology - 1 Oct 2017
Mosa Rasha, Huang Lili, Wu Yeda, Fung Chungyan, Mallawakankanamalage Oshini, LeRoith Derek, Chen Chen
Abstract excerpt
Despite the occurrence of dyslipidemia and its contribution to the development of insulin resistance in obese subjects, a growing number of studies have described abnormal lipid profiles among leaner persons. For example, individuals with an abnormal paucity or distribution of fat (lipodystrophy) develop severe insulin resistance, dyslipidemia, and hepatic steatosis. Deranged adipocyte metabolism and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
